The profession’s skepticism toward artificial intelligence may produce an unexpected benefit: a higher standard of transparency across the audit process.
Manufacturers are redesigning their processes to balance both better future emergency vaccine mobilization and the more demanding work of maintaining flexible, commercially viable manufacturing networks.
Nektar Therapeutics has been awarded $90 million in damages after a jury sided with the biotech, which had accused Big Pharma Eli Lilly of “botching” an analysis of their formerly partnered autoimmune drug.
Two RNA biotechs, ADARx Pharmaceuticals and City Therapeutics, are taking advantage of the IPO frenzy, which has led to a total of 27 newly public biotechs so far this year.
Genentech’s agreement with Earendil Labs came the same day its parent company, Roche, inked a cardiometabolic and renal deal with Atavistik Bio for up to $2 billion.
Taxpayers waited about 20 months for the IRS to process their identity theft cases in recent years, frustrating and burdening taxpayers expecting tax refunds.
Recent tax law changes are prompting businesses to rethink entity structures. Here’s what financial advisors need to know when guiding clients or making decisions about their own RIAs.
The Governmental Accounting Standards Board released an implementation guide with questions and answers clarifying the requirements related to subsidies.
Every journal entry, reconciliation and audit trail must be accurate, explainable and defensible. AI doesn’t lower that bar; it raises the stakes for meeting it.